戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 an upturn in risk in the highest quartile of serum selenium.
2 moderate inverse relationship between plasma/serum selenium and coronary heart disease.
3                  The relation between plasma/serum selenium and prostate cancer in a nonlinear dose-r
4  were to investigate the association between serum selenium and prostate cancer risk and to examine i
5 <.001), advanced stage (P =.001), and higher serum selenium concentration (P =.032).
6 y was undertaken to test the hypothesis that serum selenium concentration at presentation correlates
7                                              Serum selenium concentration at presentation is a progno
8                                              Serum selenium concentration correlated closely with per
9                                          The serum selenium concentration ranged from 0.33 to 1.51 mi
10  authors explored Black/White differences in serum selenium concentration.
11 hat Blacks had lower unadjusted and adjusted serum selenium concentrations relative to Whites is intr
12                                   Crude mean serum selenium concentrations were 126.35 ng/ml for Whit
13                        Greater prediagnostic serum selenium concentrations were not associated with p
14             Furthermore, among smokers, high serum selenium concentrations were related to reduced pr
15                                         Mean serum selenium concentrations, both crude and adjusted f
16  with FEV1 in smokers than nonsmokers, while serum selenium had a stronger positive association with
17                                              Serum selenium in prospectively collected samples was co
18                      The association between serum selenium levels and the prevalence of peripheral a
19 disease prevalence decreased with increasing serum selenium levels up to 150-160 ng/mL, followed by a
20 ients with sepsis syndrome commonly have low serum selenium levels.
21 l arterial disease decreased with increasing serum selenium (P for linear trend = 0.02), but there wa
22                         Adjustment for known serum selenium predictors, including a proxy for residen
23 at the risk decreased with increasing plasma/serum selenium up to 170 ng/mL.
24 r risk (P for trend = 0.70); however, higher serum selenium was associated with lower risks in men re
25                                              Serum selenium was measured by using inductively coupled
26                                     Overall, serum selenium was not associated with prostate cancer r
27 h crude and adjusted for known predictors of serum selenium, were determined for 10,779 Black and Whi
28  cross-sectional study of the association of serum selenium with the prevalence of peripheral arteria

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。